DNA Viral Vectors in Gene Therapy

Abstract

DNA viral vectors are gene‐delivery vehicles based on viral sequences.

Keywords: simian virus 40; baculovirus; vaccinia virus; Epstein–Barr virus; gene transfer

References

Condreay JP, Witherspoon SM, Clay WC and Kost TA (1999) Transient and stable gene expression in mammalian cells transduced with a recombinant Baculovirus vector. Proceedings of the National Academy of Sciences of the United States of America 96: 127–132.

Evans TJ, Brooks L and Farrell PJ (1997) A strategy for specific targeting of therapeutic agents to tumor cells of virus‐associated cancers. Gene Therapy 4: 264–267.

Grignani F, Kinsella T, Mencarelli A, et al. (1998) High‐efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Research 58: 14–19.

Ma L, Tamarina N, Wang Y, et al. (2000) Baculovirus‐mediated gene transfer into pancreatic islet cells. Diabetes 49: 1986–1991.

Mucke S, Polack A, Pawlita M, et al. (1997) Suitability of Epstein–Barr virus‐based episomal vectors for expression of cytokine genes in human lymphoma cells. Gene Therapy 4: 82–92.

Piechaczek C, Fetzer C, Baiker A, Bode J and Lipps HJ (1999) A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells. Nucleic Acids Research 27: 426–428.

Robertson ES, Ooka T and Kieff ED (1996) Epstein–Barr virus vectors for gene delivery to B lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 93: 11334–11340.

Saeki Y, Wataya‐Kaneda M, Tanaka K and Kaneda Y (1998) Sustained transgene expression in vitro and in vivo using an Epstein–Barr virus replicon vector system combined with HVJ liposomes. Gene Therapy 5: 1031–1037.

Strayer DS (1999) Gene therapy using SV40‐derived vectors: what does the future hold? Journal of Cell Physiology 181: 375–384.

Tan BT, Wu L and Berk AJ (1999) An adenovirus – Epstein–Barr virus hybrid vector that stably transforms cultured cells with high efficiency. Journal of Virology 73: 7582–7589.

Tsukamoto H, Wells DJ, Brown SC, et al. (1999) Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein–Barr virus (EBV)‐based mini‐chromosome vectors in mdx mice. Gene Therapy 6: 1331–1335.

Waldenstrom M, Schenstrom K, Sollerbrant K and Hansson L (1992) Replication of bovine papillomavirus vectors in murine cells. Gene 120: 175–181.

Wang S, Di S, Young WB, Jacobson C and Link Jr CJ (1997) A novel herpesvirus amplicon system for in vivo gene delivery. Gene Therapy 4: 1132–1141.

Further Reading

Boyce FM and Bucher NL (1996) Baculovirus‐mediated gene transfer into mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 93: 2348–2352.

Carrol MW and Moss B (1997) Poxviruses as expression vectors. Current Opinion in Biotechnology 8: 573–577.

Dwarakanath RS, Clark CL, McElroy AK and Spector DH (2001) The use of recombinant baculoviruses for sustained expression of human cytomegalovirus immediate early proteins in fibroblasts. Virology 284: 297–307.

Goebel SJ, Johnson GP, Perkus ME, et al. (1990) The complete DNA sequence of vaccinia virus. Virology 179: 247–266, 517–563.

Mackett M (1995) Construction and characterization of vaccinia virus recombinants. In: Glover D (ed.) DNA Cloning. 4. Mammalian Systems: A Practical Approach, pp. 43–83. New York, NY: Oxford University Press.

Moss B (1996) Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proceedings of the National Academy of Sciences of the United States of America 93: 11341–11348.

Shoji I, Aizaki H, Tani H, et al. (1997) Efficient gene transfer into various mammalian cells, including non‐hepatic cells, by baculovirus vectors. Journal of General Virology 78: 2657–2664.

Strayer DS (2000) SV40‐based gene therapy vectors: turning an adversary into a friend. Current Opinion in Molecular Therapy 2: 570–578.

Van Craenenbroeck K, Vanhoenacker P and Haegeman G (2000) Episomal vectors for gene expression in mammalian cells. European Journal of Biochemistry 267: 5665–5678.

Verma IM and Somia N (1997) Gene therapy – promises, problems and prospects. Nature 389: 239–242.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Van Craenenbroeck, Kathleen, Vanhoenacker, Peter, and Haegeman, Guy(Jan 2006) DNA Viral Vectors in Gene Therapy. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1038/npg.els.0005740]